8/18/2019 Case Presentation on Chronic Kidney Disease1

1/18

Presenting By Guide

B.Nagamani P.Ramakrishna

Pharm.D III year Asst.prof .in pharmacy practice

CASE PRESENTATION ON

CHRONIC IDNE! DISEASE

8/18/2019 Case Presentation on Chronic Kidney Disease1

2/18

contents

Patient Details

Chief complaints And Past History

Diagnosis

Examination And Lab Investigation

SOAP AAL!SIS

Pharmace"tical iss"es

S"ggestions and patient ed"cation

8/18/2019 Case Presentation on Chronic Kidney Disease1

3/18

PA#IE# DE#AILS

A$E%&' !EA(S

SE)% *E+ALE

(ELI$IO%HID,

(E$-O%./0.0.//1/

2ard%C

D-O-A30'%'%04

D-O-D305%'%04

8/18/2019 Case Presentation on Chronic Kidney Disease1

4/18

CHIE* CO+PLAI#S

#he patient 6as admitted 6ith the complaints of 7oint pains8 bilateral pedal

oedema since 0/ days-

She is also s"ffering from shortness of breath since 9 days-

8/18/2019 Case Presentation on Chronic Kidney Disease1

5/18

PAS# HIS#O(!

She had a past medical history of hypertension :amlodipine; and diabetes

since 09 years-

8/18/2019 Case Presentation on Chronic Kidney Disease1

6/18

E)A+IA#IOS

8/18/2019 Case Presentation on Chronic Kidney Disease1

7/18

LA< I>ES#I$A#IOS

INVESTIGATION NORMAL VALUE RESU

HEA+O$LO

8/18/2019 Case Presentation on Chronic Kidney Disease1

8/18

LA< I>ES#I$A#IOS

04=/'=./04

INVESTIGATION NORMAL VALUE RESULT

SE(,+ C(EA#IIE /-@%0-4mg=dl @-5mg

0@=/'=./04

INVESTIGATION NORMAL VALUE RESULT

SE(,+ C(EA#IIE /-@%0-4mg=dl 4-4m

8/18/2019 Case Presentation on Chronic Kidney Disease1

9/18

DIA$OSIS

CHORONIC KIDNEYDISEASE

8/18/2019 Case Presentation on Chronic Kidney Disease1

10/18

SOAP AAL!SIS

P(OIDECES3 0'=/'=./04

INVESTIGATION NORMAL VALUE RESUHEA+O$LO

8/18/2019 Case Presentation on Chronic Kidney Disease1

11/18

04=/'./04

0@=/'=./04

ASSESS+E#3

8/18/2019 Case Presentation on Chronic Kidney Disease1

12/18

#(EA#+E# OP#IOS

DRUG GENERICNAME

DRUG BRANDNAME

DOSE FREQUENCY CATAGORY

IB-IS,LI IB-H- +I)#A(D '/%0/%09I,

#ID A#I%DIA

8/18/2019 Case Presentation on Chronic Kidney Disease1

13/18

DRUG GENERICNAME

DRUG BRANDNAME

DOSE FREQUENCY CATAGORY

#A

8/18/2019 Case Presentation on Chronic Kidney Disease1

14/18

DISCHA($E +EDICA#IODRUG GENERICNAME

DRUG BRANDNAME

DOSE FREQUENCY CATAGORY

#A

8/18/2019 Case Presentation on Chronic Kidney Disease1

15/18

Pharmaceutical issues

As!"!# $ M%&'"'l'l

aspirin decreases effects of metoprolol by pharmacodynamic antagonism- Significan

interaction possible8 monitor closely- Long term :0 6; SAID "se- SAIDs decrease

prostaglandin synthesis-

metoprolol and aspirin both increase ser"m potassi"m- Potential for interaction8 mo

M%&'"'l'l $ F("'s%m!d%

metoprolol increases and f"rosemide decreases ser"m potassi"m- Effect of interacti

clear8 "se ca"tion- Potential for interaction8 monitor-

As!"!# $ F("'s%m!d%

aspirin increases and f"rosemide decreases ser"m potassi"m- Effect of interaction is"se ca"tion- Potential for interaction8 monitor-

High doses of glimepride 6as given to the patient b"t high doses sho"ld not be given

patient having D+ beca"se it ca"ses hypoglycaemia-

8/18/2019 Case Presentation on Chronic Kidney Disease1

16/18

Suggestions and patient education

As the patient 6as s"ffering 6ith diabetes mellit"s advised to maintain foot

care-

Advised to follo6 reg"lar medication as directed by the physician-

Patient 6as explained abo"t all the disease that she 6as s"ffering 6ith-

Patient m"st tae lo6 fat containing foods-

8/18/2019 Case Presentation on Chronic Kidney Disease1

17/18

Life style modifications

#he patient is advised to tae more calci"m rich diet-

Patient also advised to tae meals in m"ltiple time 6ith small amo"nt

Patient advised not to do heavier 6ors the may ca"se hypertension-

Patient 6as adviced to tae lo6 salt containing foods as she 6as s"ffering

from hypertension-

8/18/2019 Case Presentation on Chronic Kidney Disease1

18/18

#HA , ALL